LSBio
IHC-plus™ Monoclonal Mouse anti-Human LGALS9 / Galectin 9 Antibody (clone 1G3, IHC, WB)

Human Small Intestine: Formalin-Fixed, Paraffin-Embedded (FFPE)

IHC-plus™ Monoclonal Mouse anti-Human LGALS9 / Galectin 9 Antibody (clone 1G3, IHC, WB)

Primary AntibodyLSBio Guarantee
Antibody:Mouse Monoclonal
Applications:Immunohistochemistry (general), Immunohistochemistry, Paraffin, Western Blot
Reactivity:Human
Format:Liquid
See all LGALS9 / Galectin 9 antibodies →
$383.00each
Catalog Number: LS-B12783-50

For bulk orders or custom formulations:

Request a Quote

Overview

Description
Galectin 9 antibody LS-B12783 is an unconjugated mouse monoclonal antibody to human Galectin 9 (LGALS9). Validated for IHC and WB. Tested on 20 paraffin-embedded human tissues. Cited in 1 publication.
Application
IHC, IHC-P, WB
Reactivity
Hu
Intended Use
Research Use Only
Guarantees
This product carries the LSBio 100% Guarantee.
Category
Antibodies > Primary Antibodies > Monoclonal Antibodies
Alternative Names
Gal-9 | HUAT | Galectin 9 | Galectin-9 | LGALS9A | Tumor antigen HOM-HD-21 | Ecalectin | LGALS9
Recommended Dilution: IHC-P
10 µg/ml
Recommended Dilution: WB
1:2000
UniProt Number
O00182
SwissProt
O00182

Target

Target
LGALS9 / Galectin 9
Antigen Species
Human
Specificity
Human LGALS9 / Galectin 9
Epitope
Human LGALS9 / Galectin 9
Gene Name
LGALS9

Antibody

Host Species
Mouse
Clonality
Monoclonal
Clone
1G3
Origin Species
Human

Immunogen

Immunogen
Full length human recombinant protein of human LGALS9 (NP_002299) produced in HEK293T cell.
Immunogen Type
Full-Length Recombinant Protein

Format

Conjugate/Label
Unconjugated
Format
Liquid
Formulation
PBS, pH 7.3, 0.02% Sodium Azide, 50% Glycerol, 1% BSA
Concentration
1 mg/mL
Volume
50 Microliter
Animal Free
No
Carrier-Free
No
Preservative
Yes
Purification Method
Affinity Purified

Storage & Handling

Storage Conditions
Store at -20°C. Avoid freeze-thaw cycles.
Recommended Storage Buffer
PBS
Elevated cerebrospinal fluid Galectin-9 is associated with central nervous system immune activation and poor cognitive performance in older HIV-infected individuals. Thomas A Premeaux, Michelle L D'Antoni, Mohamed Abdel-Mohsen, Satish K Pillai, Kalpana J Kallianpur, Beau K Nakamoto, Melissa Agsalda-Garcia, Bruce Shiramizu, Cecilia M Shikuma, Magnus Gisslén, Richard W Price, Victor Valcour, Lishomwa C Ndhlovu. Journal of neurovirology. 2019 April;25:150-161. PubMed: 30478799 PMC: PMC6506351

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at: technical@vectorlabs.com.